These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31434247)

  • 1. Inhibition of Influenza A Virus by Human Infant Saliva.
    Gilbertson B; Edenborough K; McVernon J; Brown LE
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31434247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid content in human saliva and anti-influenza activity against human and avian influenza viruses.
    Limsuwat N; Suptawiwat O; Boonarkart C; Puthavathana P; Wiriyarat W; Auewarakul P
    Arch Virol; 2016 Mar; 161(3):649-56. PubMed ID: 26671828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edible bird's nest extract inhibits influenza virus infection.
    Guo CT; Takahashi T; Bukawa W; Takahashi N; Yagi H; Kato K; Hidari KI; Miyamoto D; Suzuki T; Suzuki Y
    Antiviral Res; 2006 Jul; 70(3):140-6. PubMed ID: 16581142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy.
    Matsubara T; Onishi A; Yamaguchi D; Sato T
    Bioorg Med Chem; 2016 Mar; 24(5):1106-14. PubMed ID: 26833245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives.
    Honda T; Masuda T; Yoshida S; Arai M; Kobayashi Y; Yamashita M
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1921-4. PubMed ID: 12113809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of proteins with Siaα2-3/6Gal-linked glycans from bovine milk and role of their glycans against influenza A virus.
    Yu H; Zhong Y; Zhang Z; Liu X; Zhang K; Zhang F; Zhang J; Shu J; Ding L; Chen W; Du H; Zhang C; Wang X; Li Z
    Food Funct; 2018 Oct; 9(10):5198-5208. PubMed ID: 30178807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of potent sialidase-based inhibitors of influenza virus replication.
    von Itzstein M; Wu WY; Kok GB; Pegg MS; Dyason JC; Jin B; Van Phan T; Smythe ML; White HF; Oliver SW
    Nature; 1993 Jun; 363(6428):418-23. PubMed ID: 8502295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors.
    Suzuki K; Koyama T; Yingsakmongkon S; Suzuki Y; Hatano K; Matsuoka K
    Bioorg Med Chem; 2012 Jan; 20(1):446-54. PubMed ID: 22100261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets.
    Oh DY; Panozzo J; Vitesnik S; Farrukee R; Piedrafita D; Mosse J; Hurt AC
    Antivir Ther; 2018; 23(4):295-306. PubMed ID: 28195559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.
    Honda T; Yoshida S; Arai M; Masuda T; Yamashita M
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1929-32. PubMed ID: 12113811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
    Mendel DB; Tai CY; Escarpe PA; Li W; Sidwell RW; Huffman JH; Sweet C; Jakeman KJ; Merson J; Lacy SA; Lew W; Williams MA; Zhang L; Chen MS; Bischofberger N; Kim CU
    Antimicrob Agents Chemother; 1998 Mar; 42(3):640-6. PubMed ID: 9517945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-bound sialic acid in saliva contributes directly to salivary anti-influenza virus activity.
    Kobayashi K; Shono C; Mori T; Kitazawa H; Ota N; Kurebayashi Y; Suzuki T
    Sci Rep; 2022 Apr; 12(1):6636. PubMed ID: 35459785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-influenza virus evaluation of triterpene-sialic acid conjugates.
    Tsuji M; Sriwilaijaroen N; Inoue H; Miki K; Kinoshita K; Koyama K; Furuhata K; Suzuki Y; Takahashi K
    Bioorg Med Chem; 2018 Jan; 26(1):17-24. PubMed ID: 29198893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs.
    An L; Liu R; Tang W; Wu JG; Chen X
    Antiviral Res; 2014 Sep; 109():54-63. PubMed ID: 24971493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for evaluation of antiviral efficacy against influenza virus infections in animal models.
    Smee DF; Barnard DL
    Methods Mol Biol; 2013; 1030():407-25. PubMed ID: 23821285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of sialic acid derivatives having a C=C double bond substituted at the C-5 position and their glycopolymers.
    Suzuki K; Sakamoto J; Koyama T; Yingsakmongkon S; Suzuki Y; Hatano K; Terunuma D; Matsuoka K
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5105-8. PubMed ID: 19631531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral effect of a derivative of isonicotinic acid enisamium iodide (FAV00A) against influenza virus.
    Cocking D; Cinatl J; Boltz DA; Peng X; Johnson W; Muzzio M; Syarkevych O; Kostyuk G; Goy A; Mueller L; Margitich VI
    Acta Virol; 2018; 62(2):191-195. PubMed ID: 29895160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microparticle and anti-influenza activity in human respiratory secretion.
    Suptawiwat O; Ruangrung K; Boonarkart C; Puthavathana P; Maneechotesuwan K; Charngkaew K; Chomanee N; Auewarakul P
    PLoS One; 2017; 12(8):e0183717. PubMed ID: 28832645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
    Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
    Front Immunol; 2019; 10():60. PubMed ID: 30761132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.